Development of monothiol human thioredoxin-1 (ORP100S) as an inhaled treatment for acute viral lung injury

Ended Project Grant Awarded Last action

Award ID
W81XWH2210613
Recipient
Awarding agency
Obligated
$4,294,046

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Funding
  • $2,147,023.00 Federal
  • $2,147,023.00 Non-federal
Place of performance
San Diego, CA 92131, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment This modif ication: 1. Extends the POP by 12 months. Technical and financial reporting shall continue in accordance W ITH the AW ARD terms and conditions. 2.… $0 $0
Amendment $0 $0
Original award $2,147,023 $2,147,023

Quick answers

Who received award W81XWH2210613?

W81XWH2210613 was awarded to Orpro Therapeutics Inc. by Defense Health Agency (Department of Defense) on July 1, 2022.

How much is award W81XWH2210613 worth?

$4,294,046 has been obligated on W81XWH2210613: $2,147,023 in federal funding and $2,147,023 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login